| Preview | Issue Date | Title | Author(s) | Access |
 | 12-Apr-2024 | Clinical prediction of opioid use disorder in chronic pain patients: a cohort-retrospective study with a pharmacogenetic approach | Escorial, Mónica; Muriel, Javier; Agulló, Laura; Zandonai, Thomas; Margarit, César; Morales, Domingo; Peiró, Ana |  |
 | 3-Jul-2023 | CYP2D6 Genotype and Pharmacovigilance Impact on Autism Spectrum Disorder: A Naturalistic Study with Extreme Phenotype Analysis | Ballester, Purificación; Espadas, Cristina; Almenara, Susana; Barrachina, Jordi; Muriel, Javier; Ramos, Enrique; Toral, Natalia; Belda, César; Peiró, Ana | |
 | Apr-2022 | CYP2D6 phenotypes and opioid metabolism: the path to personalized analgesia | Ballester, Purificación; Muriel, Javier; Peiró, Ana |  |
 | Oct-2021 | Disfunción eréctil en pacientes con enfermedad cardiovascular y potencial influencia de marcadores genéticos | Ors, Diego; Segura, Ana; Ballester, Purificación; Muriel, Javier; Fernández, Guillermina; Soriano, Josefa; Peiró, Ana | |
 | 2019 | Endothelial nitric oxide synthase gene polymorphisms and erectile dysfunction in chronic pain | Segura, Ana; Ballester, Purificación; Ajo Ferrer, Raquel; Inda, María del Mar; Urbano, Antonio; Muriel, Javier; Ochando, Isabel; Margarit, César; Martinez, Emi; Peiró, Ana | |
 | Nov-2019 | Evaluation of agomelatine for the treatment of sleep problems in adults with autism spectrum disorder and co-morbid intellectual disability | Ballester, Purificación; Martínez, María José; Inda, María del Mar; Javaloyes, María Auxiliadora; Richdale, Amanda; Muriel, Javier; Belda, César; Toral, Natalia; Morales, Domingo; Fernández, Eduardo; Peiró, Ana | |
 | Sep-2022 | Food ProteineInduced Enterocolitis Syndrome in Adulthood: Clinical Characteristics, Prognosis, and Risk Factors | González-Delgado, Purificación; Muriel, Javier; Jiménez, Teodorikez; Cameo, José Ignacio; Palazón-Bru, Antonio; Fernández, Javier | |
 | Apr-2020 | Gender based differences, pharmacogenetics and adverse events in chronic pain management | Planelles, Beatriz; Margarit, César; Inda, María del Mar; Ballester, Purificación; Muriel, Javier; Barrachina, Jordi; Ajo Ferrer, Raquel; Esteban, maría Dolores; Peiró, Ana | |
 | Nov-2019 | Genetic Contribution in Low Back Pain: A Prospective Genetic Association Study | Margarit, César; Roca, Reyes; Inda, María del Mar; Muriel, Javier; Ballester, Purificación; Moreu, Rocio; CONTE, LUCIA; Nuñez, Ángela; Morales, Domingo; Peiró, Ana | |
 | May-2021 | Global Pain State Questionnaire: Reliability, Validity, and Gender Gap | Barrachina, Jordi; Muriel, Javier; Margarit, César; Planelles, Beatriz; Ballester, Purificación; Miguel, Richart-Martínez; Cutillas, Esperanza; Zandonai, Thomas; Peiró, Ana | |
 | 2023 | Impact of CYP2D6 genotype on opioid use disorder deprescription: an observational prospective study in chronic pain with sex-differences | Muriel, Javier; Barrachina, Jordi; Del Barco, Guillermo; Carvajal, Cristian; Escorial, Mónica; Margarit, César; Ballester, Purificación; Peiró, Ana María | |
 | 18-Nov-2022 | Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences | Muriel, Javier; Escorial, Mónica; Margarit, César; Barrachina, Jordi; Carvajal, Cristian; Morales, Domingo; Peiró, Ana | |
 | 2018 | OPRM1 influence on and effectiveness of an individualized treatment plan for prescription opioid use disorder patients | Muriel, Javier; Margarit, César; Planelles, Beatriz; Serralta, María J.; Puga, Carmen; Inda, María del Mar; Cutillas, Esperanza; Morales, Domingo; Horga, José F. | |
 | Jun-2022 | Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study | Barrachina, Jordi; Margarit, César; Muriel, Javier; López‑Gil, Santiago; López Gil, Vicente; Vara-González, Amaya; Planelles, Beatriz; Inda, María del Mar; Morales, Domingo; Peiró, Ana | |
 | 2022 | Oxycodone/naloxone versus tapentadol in real‑world chronic non‑cancer pain management: an observational and pharmacogenetic study | Barrachina, Jordi; Margarit, Cesar; Muriel, Javier; López‑Gil, Santiago; López Gil, Vicente; Vara-González, Amaya; Planelles, Beatriz; Inda, María del Mar; Morales, Domingo; Peiró, Ana María | |
 | 2023 | Pharmacogenetic Guided Opioid Therapy Improves Chronic Pain Outcomes and Comorbid Mental Health: A Randomized, Double-Blind, Controlled Study | Agulló, Laura; Aguado, Isidro; Muriel, Javier; Margarit, César; Gómez, Alba; Escorial, Mónica; Sánchez, Astrid; Fernández, Alicia; Peiró, Ana | |
 | 2018 | Pharmacogenetics and prediction of adverse events in prescription opioid use disorder patients | Muriel, Javier; Margarit, César; Barrachina, Jordi; Ballester, Purificación; Flor, Andrea; Morales, Domingo; Horga, José F.; Fernández, Eduardo; Peiró, Ana | |
 | 2022 | Sex-Differences in Pain and Opioid Use Disorder Management: A Cross-Sectional Real-World Study | Escorial, Mónica; Muriel, Javier; César, Margarit; Laura, Agulló; Domingo, Morales; Peiró, Ana | |
 | May-2021 | The challenge of detecting adverse events in adults with autism spectrum disorder who have intellectual disability | Ballester, Purificación; Espadas, Cristina; Londoño, Ana C.; Almenara, Susana; Aguilar, Víctor; Belda, César; Pérez, Enrique; Muriel, Javier; Peiró, Ana | |
 | 26-Jul-2019 | Tratamiento del trastorno por consumo de opioides de prescripción, en pacientes con dolor crónico no oncológico: efectividad, seguridad y marcadores farmacogenéticos | Muriel, Javier | |
.png){kind=logo}